Betterchem   

 
    Chemistry, Manufacturing, and Controls Information…

Key Data Files for this
Active Pharmaceutical Ingredient:
 

 

 

 


 


  • Drug Master Files, 21 CFR, and other industry portals

  • Patent/Exclusivity data file

  • Drug Approval

  • Drug Safety

  • Freedom of Information

  • Federal Register pages

  • Pharma Companies

  • Pharmacopeial Information

  • Preferred API Supplier (Clients Only)

    •  
                                                                   

     

    FDA Approval Activities for this Drug…

    Cozaar (losartan potassium) Tablets, Merck & Co., NDA 20-386/S032 3/25/03 4/1/03 4/1/03 7/8/03 Cozaar (losartan potassium) Tablets, 25, 50, & 100 mg, Merck & Co., NDA 20-386/S028 9/17/02 9/20/02 9/17/02 2/4/03 Cozaar (losartan potassium) Tablets, 25, 50, & 100 mg; Hyzaar (losartan potassium / hydrochlorothiazide) Tablets, 50-12.5 & 100-25 Merck & Co., NDA 20-386/S020 & 20-387/S017 1/19/00 6/6/01 Cozaar (losartan potassium) Tablets, 25, 50, & 100 mg; Hyzaar (losartan potassium / hydrochlorothiazide) Tablets, 50-12.5 & 100-25 Merck & Co., NDA 20-386/S018 & 20-387/S014 1/28/00 6/6/01 Cozaar (losartan potassium) Tablets, 25 & 50 mg Merck Research NDA 20-386/S-015 11/24/98 3/13/00 Cozaar (losartan potassium) Tablets, 25 & 50 mg Merck Research NDA 20-386/S-008 10/13/98 9/14/01 Cozaar (losartan potassium) Tablets, 25 & 50 mg Merck & Co. NDA 20-386/S-017 Hyzaar (losartan potassium/hydrochlorothiazide), Merck & Co., NDA 20-387/S-013 & S-015 & S-027 9/30/03 10/10/03 10/10/03 Hyzaar (losartan potassium/hydrochlorothiazide) Tablets, 50/12.5 and 100/25 mg. Merck & Co., NDA 20-387/S-024 11/7/02 11/18/02 Hyzaar (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg Merck Research NDA 20-387/S6 8/24/98 12/3/01 Hyzaar (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg Merck Research NDA 20-387/S8 11/10/98 12/3/01 Hyzaar 50-12.5 (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg Merck Research NDA 20-387/S10 8/25/98 12/3/01 Hyzaar 50 (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg Merck Research NDA 20-387/S-011 11/24/98 3/13/00 Hyzaar 50 (losartan potassium/hydrochlorothiazide) Tablets, 50-12.5 mg & 100-25 mg Merck Research NDA 20-387/S-012 Cozaar (losartan potassium) Tablets, Merck and Co., Inc.
     

    For the latest approval information, locate this drug using this index.
     

     
    A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

    Health | Pharma News | DMF Index | Search | Pharma Industry Portals | Site Map

    © 2009 Betterchem.com